Immunotherapy in Kidney Cancer

0 Views
administrator
administrator
06/26/23

Thomas Hutson, DO, PharmD, FACP; James J. Hsieh, MD, PhD; and Martin H. Voss, MD, explain the clinical rationale for immunotherapeutic approaches in the treatment of renal cell carcinoma and the current role for immunotherapy agents.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next